Experiences with

Acute leukaemia

Please join us for the 3rd in the series of acute leukaemia treatment updates. This webinar will update on how ALL is treated today and what is on the horizon: how is a therapy chosen, how is prognosis determined and what level of involvement should patients expect in their care decisions.

Please join us for our 2nd webinar in the acute leukaemia treatment updates series. This webinar will update on how AML is treated today and what is on the horizon: how is a therapy chosen, how is prognosis determined and what level of involvement should patients expect in their care decisions.

Please join us for the 1st in our series of free treatment updates in acute leukaemia. This webinar will update on how APL is treated today and what is on the horizon: how is a therapy chosen, how is prognosis determined and what level of involvement should patients expect in their care decisions.

Date: Wednesday 13th January 2021 Time: 9:30am Guests: Dr Amit Patel, Consultant Haematologist, Cellular Therapies and Transplantation, The Christie NHS Foundation Trust Dr Steven Knapper, Clinical Senior Lecturer in Haematology and consultant haematologist, University Hospital of Wales. Kate Stallard

10th August at 11am – Launch meeting – Hosted by Jessica Turner, Leukaemia Care North-West Regional Coordinator. Our Acute Myeloid Leukaemia (AML) North Virtual Support Group is for anyone who has been diagnosed with AML in the North of England.

Dr Patel will discuss the potential changes to your care as a result of the coronavirus outbreak as well as providing advice on living with acute leukaemia at this time. Weds 8th April 10.15am Register here https://zoom.us/webinar/register/WN_KeFZJqvmSZ6UEkVptgaaQw

These webinars on acute leukaemia and chronic lymphocytic leukaemia (CLL) can now be found on our YouTube > In the videos leading consultants are joined by patients as they discuss and answer questions about how COVID-19 is affecting leukaemia patients.

Our friendly virtual support group is open to anybody from the south of the UK that has been affected by a acute myeloid leukaemia diagnosis. This is a great opportunity to meet new people and share in real time your experiences.

University of Birmingham and Queen Elizabeth Hospital, Birmingham Gillian Marshall, Haematology CNS at Queen Elizabeth Hospital, Birmingham Samantha Slaney, acute myeloid leukaemia (AML) patient Nick York, chronic lymphocytic leukaemia (CLL) patient and Patient Advocacy Healthcare Liaison Officer

University of Birmingham and Queen Elizabeth Hospital, Birmingham Gillian Marshall, Haematology CNS at Queen Elizabeth Hospital, Birmingham Samantha Slaney, acute myeloid leukaemia (AML) patient Nick York, chronic lymphocytic leukaemia (CLL) patient and Patient Advocacy Healthcare Liaison Officer

Whilst there, the team spoke to a number of experts, in these first two videos we hear from Professor Anthony Moorman on how genetic information about the leukaemia cell is used in the diagnosis and treatment of acute leukaemia, along with what research was presented on the topic of genetics and acute

She had a bone marrow transplant 11 yrs ago as she had acute lymphoblastic leukaemia. Is there anyone out there in the same situation?

syndrome and acute myeloid leukaemia across PARP inhibitor groups was 0·73% (... 21 events out of 4533 patients) and across placebo groups was 0·47% (... three events out of 2774 patients)."

Hi is the forum still active for Acute lymphoblastic leukaemia on this site. I can only see CLL posts. Thanks Hayley

In this video interview Dr Sara Ghorashian describes the remaining challenges in the treatment of childhood acute lymphoblastic leukaemia (ALL), and how these could be addressed. https://youtu.be/o4R9V5OeQoU

In approx. 15-20% of SWEET'S SYNDROME patients, their condition can be triggered by CANCER, one of the commonest being myelodyplastic syndromes which can progress to acute myeloid leukaemia.

« Interferon-alpha (rIFNα) is the only disease-modifying treatment for polycythemia vera (PV), but whether or not it prolongs survival is unknown. This large single center retrospective study of 470 PV patients compares the myelofibrosis-free survival (MFS) and overall survival (OS) with rIFNα to two

It has taken me some time to write this... but I hope my husband’s journey with MPN is perceived overall a message hope to others. He was diagnosed with PV aged 46 and had a great quality of life for 28 years ,needing only phlebotomy -initially weekly but eventually every six weeks or so . He progressed

Morning.. I am a MF patient, (52 working full time), and for a while have been interested in how nutrition can help me. I can be very good about a varied diet, and then get bored of it, or the perceived effort of planning and doing etc.... However lockdown has made eating well harder, shopping online

Hi! I am new to this. You guys Who have ET, did you have any raising levels in LDH? Or anything else other than high platelets? How is the prognosis with prefibrotic myelofibrosis? Do everyone get myelofibrosis? Thank you!